Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series
- DOI
- 10.33393/dti.2025.3616
- Published
- 2025-12-09
- Container
- Drug Target Insights
- Publisher
- Aboutscience Srl
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.33393/dti.2025.3616,
title = {Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series},
author = {Livia Maria Sorrentino and Candida Iacuzzo and Raffaella Sciri and Miriam Zacchia and Mariarosaria Iannuzzi and Paola Marotta and Piercarla Vitale and Chiara Taglioni and Floriana Secondulfo and Daniela Palazzetti and Rocco Baccaro},
year = {2025},
journal = {Drug Target Insights},
doi = {10.33393/dti.2025.3616},
url = {https://doi.org/10.33393/dti.2025.3616}
}RIS
TY - JOUR TI - Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series AU - Livia Maria Sorrentino AU - Candida Iacuzzo AU - Raffaella Sciri AU - Miriam Zacchia AU - Mariarosaria Iannuzzi AU - Paola Marotta AU - Piercarla Vitale AU - Chiara Taglioni AU - Floriana Secondulfo AU - Daniela Palazzetti AU - Rocco Baccaro PY - 2025 JO - Drug Target Insights DO - 10.33393/dti.2025.3616 UR - https://doi.org/10.33393/dti.2025.3616 ER -
APA
Sorrentino, L. M., Iacuzzo, C., Sciri, R., Zacchia, M., Iannuzzi, M., Marotta, P., Vitale, P., Taglioni, C., Secondulfo, F., Palazzetti, D., & Baccaro, R. (2025). Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series. Drug Target Insights. https://doi.org/10.33393/dti.2025.3616
Source records
- crossref · retrieved 2026-09-25T06:41:46.563Z